Výsledky vyhledávání

Factors affecting hemopoietic recovery after high-dose therapy and autologous peripheral blood progenitor cell transplantation: a single center experience

Autor: A, Olivieri, M, Offidani, M, Montanari, L, Ciniero, I, Cantori, L, Ombrosi, C M, Masia, R, Centurioni, S, Mancini, M, Brunori, P, Leoni

Publikováno v: Haematologica. 83(4)

While the minimum number of CD34+ cells required for complete and long-lasting engraftment is quite well established, there is not general agreement about the optimal number of CD34+ per kg needed in order to obtain engraftment as rapidly as possible

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::0848f70a9021a0268a513a23e1a0a703
https://pubmed.ncbi.nlm.nih.gov/9592983

Zobrazit plný text záznamu

Addition of erythropoietin to granulocyte colony-stimulating factor after priming chemotherapy enhances hemopoietic progenitor mobilization

Autor: A, Olivieri, M, Offidani, I, Cantori, L, Ciniero, L, Ombrosi, M C, Masia, M, Brunori, M, Montroni, P, Leoni

Publikováno v: Bone marrow transplantation. 16(6)

Hemopoietic progenitor cell mobilization intended for autotransplantation is now feasible in many patients, following the administration of single cytokines (G-CSF, GM-CSF, IL-3) or their combination. Erythropoietin (EPO) is a cytokine which showed a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::74bf7879edbb44d18c938b1105e4f704
https://pubmed.ncbi.nlm.nih.gov/8750267

Zobrazit plný text záznamu

DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma

Autor: A, Olivieri, M, Offidani, L, Ciniero, I, Cantori, L, Ombrosi, S, Mancini, M C, Masia, P, Scalari, P, Leoni

Publikováno v: Bone marrow transplantation. 16(1)

We studied 14 patients affected by lymphoma to assess the toxicity, efficacy and mobilization capability of salvage DHAP regimen followed by G-CSF 5 micrograms/kg/day. Ten patients were affected by intermediate-grade NHL and 4 by HD; all of them were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::af349ef3036b65df1c88479fa43c8497
https://pubmed.ncbi.nlm.nih.gov/7581135

Zobrazit plný text záznamu

Optimization of the yield of PBSC for autotransplantation mobilized by high-dose chemotherapy and G-CSF: proposal for a mathematical model

Autor: A, Olivieri, M, Offidani, L, Ciniero, A, Poloni, M C, Masia, A, Salvi, P, Leoni

Publikováno v: Bone marrow transplantation. 14(2)

We analyzed the results of 71 leukapheresis procedures performed in 21 patients to identify the best predictive factors affecting the yield of peripheral blood progenitors after high-dose chemotherapy followed by G-CSF administration. An average of 1

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b766c1403c4784a7d68f62161d75610d
https://pubmed.ncbi.nlm.nih.gov/7527687

Zobrazit plný text záznamu

PBSC collection after high dose chemotherapy followed by G-CSF in patients with malignancies: analysis of results regarding factors affecting the yield of hemopoietic progenitors

Autor: A, Olivieri, M, Offidani, L, Ciniero, A, Poloni, A, Tedeschi, M C, Refe, A S, Strusi, P, Leoni

Publikováno v: The International journal of artificial organs. 16

High-dose non ablative chemotherapy followed by growth factors efficiently mobilizes and amplifies Peripheral Blood stem Cells (PBSC). Cytofluorimetric PBSC monitoring reduces the number of leukapheresis needed to collect sufficient amounts of progen

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a8b4bf50e3f0ea6952c0278fda8068f0
https://pubmed.ncbi.nlm.nih.gov/7516918

Zobrazit plný text záznamu

[Differentiating agents in myelodysplastic syndromes. Analysis of personal cases]

Autor: A, Olivieri, P, Leoni, L, Ciniero, M, Offidani, M, Montillo, H, Ziarati, R, Centurioni, F, Brianzoni, A, Salvi, G, Danieli

Publikováno v: Recenti progressi in medicina. 84(3)

The Myelo-Dysplastic Syndromes are a heterogeneous group of diseases which includes patients with different prognosis. There is no agreement about the management and the therapeutic strategy must be based on many individual parameters, particularly t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::99e12dc4cdbc9a44a5c34449a1447d29
https://pubmed.ncbi.nlm.nih.gov/8465097

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání